These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 11350897

  • 1. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y, Nishiguchi S, Tamori A, Koh N, Yano Y, Kubo S, Hirohashi K, Otani S.
    Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
    [Abstract] [Full Text] [Related]

  • 2. Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas.
    Hui AM, Kanai Y, Sakamoto M, Tsuda H, Hirohashi S.
    Hepatology; 1997 Mar; 25(3):575-9. PubMed ID: 9049201
    [Abstract] [Full Text] [Related]

  • 3. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 4. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
    Shi YZ, Hui AM, Takayama T, Li X, Cui X, Makuuchi M.
    Br J Cancer; 2000 Jul 15; 83(1):50-5. PubMed ID: 10883667
    [Abstract] [Full Text] [Related]

  • 5. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
    Naka T, Toyota N, Kaneko T, Kaibara N.
    Anticancer Res; 1998 Jul 15; 18(1B):555-64. PubMed ID: 9568177
    [Abstract] [Full Text] [Related]

  • 6. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].
    Zhu B, Cong W, Wang H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec 15; 7(4):217-20. PubMed ID: 10715791
    [Abstract] [Full Text] [Related]

  • 7. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage.
    Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T.
    Nature; 1996 Aug 29; 382(6594):816-8. PubMed ID: 8752276
    [Abstract] [Full Text] [Related]

  • 8. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF, Ng IO.
    Hum Pathol; 2001 Aug 29; 32(8):778-84. PubMed ID: 11521219
    [Abstract] [Full Text] [Related]

  • 9. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
    Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H, Hirohashi S.
    Hepatology; 1999 Mar 29; 29(3):703-9. PubMed ID: 10051471
    [Abstract] [Full Text] [Related]

  • 10. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
    Tamori A, Nishiguchi S, Nishikawa M, Kubo S, Koh N, Hirohashi K, Shiomi S, Inoue M.
    J Gastroenterol; 2004 Nov 29; 39(11):1063-8. PubMed ID: 15580399
    [Abstract] [Full Text] [Related]

  • 11. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
    Yuan RH, Jeng YM, Chen HL, Hsieh FJ, Yang CY, Lee PH, Hsu HC.
    Clin Cancer Res; 2005 Apr 01; 11(7):2568-75. PubMed ID: 15814635
    [Abstract] [Full Text] [Related]

  • 12. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Apr 01; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 13. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
    Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY.
    Cancer Res; 1993 Oct 01; 53(19):4691-4. PubMed ID: 8402647
    [Abstract] [Full Text] [Related]

  • 14. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K.
    J Gastroenterol; 2004 Oct 01; 39(4):355-61. PubMed ID: 15168247
    [Abstract] [Full Text] [Related]

  • 15. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K.
    Cancer Res; 2003 Sep 15; 63(18):5785-92. PubMed ID: 14522900
    [Abstract] [Full Text] [Related]

  • 16. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug 15; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 17. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G, Kremer-Tal S, Matsumoto N, Zhao X, Yao S, Kelley K, Tarocchi M, Friedman SL.
    Oncogene; 2007 Jun 28; 26(30):4428-34. PubMed ID: 17297474
    [Abstract] [Full Text] [Related]

  • 18. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
    Hsia CC, Nakashima Y, Thorgeirsson SS, Harris CC, Minemura M, Momosaki S, Wang NJ, Tabor E.
    Oncol Rep; 2000 Jun 28; 7(2):353-6. PubMed ID: 10671685
    [Abstract] [Full Text] [Related]

  • 19. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 20. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y.
    Hokkaido Igaku Zasshi; 1994 Sep 25; 69(5):1252-60. PubMed ID: 7868063
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.